Sulphasalazine in ulcerative colitis: in memoriam?

This publication has 26 references indexed in Scilit:

• EFFECT OF SULPHASALAZINE AND ITS METABOLITES ON MITOGEN INDUCED TRANSFORMATION OF LYMPHOCYTES—CLUES TO ITS CLINICAL ACTION?
  Rheumatology, 1988
• EXACERBATION OF DIARRHOEA AND PAIN IN PATIENTS TREATED WITH 5-AMINOSALICYLIC ACID FOR ULCERATIVE COLITIS
  The Lancet, 1984
• Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease
  New England Journal of Medicine, 1980
• EFFECTS OF SULPHASALAZINE AND ITS METABOLITES ON PROSTAGLANDIN SYNTHESIS, INACTIVATION AND ACTIONS ON SMOOTH MUSCLE
  British Journal of Pharmacology, 1980
• Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.
  Gut, 1980
• Capacity-limited Gut Wall Metabolism of 5-aminosalicylic acid, a Therapeutically Active Metabolite of Sulfasalazine, in Rats
  Journal of Pharmaceutical Sciences, 1979
• The Effect of Sulfasalazine and Its Active Components on Human Polymorphonuclear Leukocyte Function in Relation to Ulcerative Colitis
  Acta Medica Scandinavica, 1979
• Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype
  New England Journal of Medicine, 1973
• Comparative Nephrotoxicity of Aspirin and Phenacetin Derivatives
  BMJ, 1971
• SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITIS
  The Lancet, 1962